Free Trial

Curaleaf (OTCMKTS:CURLF) Stock Price Up 3.8% - What's Next?

Curaleaf logo with Medical background

Key Points

  • Curaleaf stock price rose by 3.8% to $2.45 amidst a significant drop in trading volume, down 78% from the average session.
  • Cormark upgraded Curaleaf's shares from a "hold" to a "moderate buy" rating, contributing to the stock's positive sentiment among analysts with a consensus rating of "Strong Buy".
  • The company reported earnings of ($0.06) per share, beating expectations, while analysts forecast a negative EPS of -0.25 for the current year.
  • MarketBeat previews top five stocks to own in November.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s stock price was up 3.8% on Tuesday . The stock traded as high as $2.45 and last traded at $2.45. Approximately 175,415 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 815,115 shares. The stock had previously closed at $2.36.

Analyst Ratings Changes

Separately, Cormark raised Curaleaf from a "hold" rating to a "moderate buy" rating in a report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, Curaleaf has a consensus rating of "Strong Buy".

Read Our Latest Stock Report on Curaleaf

Curaleaf Trading Down 0.2%

The firm has a market capitalization of $1.74 billion, a PE ratio of -8.13 and a beta of 0.78. The firm's 50-day simple moving average is $2.25 and its 200-day simple moving average is $1.36. The company has a quick ratio of 0.70, a current ratio of 1.47 and a debt-to-equity ratio of 1.00.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative return on equity of 14.61% and a negative net margin of 18.08%. Equities analysts expect that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Articles

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.